1999
DOI: 10.1111/j.1600-0560.1999.tb01864.x
|View full text |Cite
|
Sign up to set email alerts
|

Trichoepithelioma: a 19‐year clinicopathologic re‐evaluation

Abstract: Accurate histopathologic distinction between trichoepithelioma (TE) and basal cell carcinoma (BCC) may be challenging. From 97 cases diagnosed as TE during the period 1979-1997, 73 available cases were studied with regard to: 1) stroma; 2) retraction effect; 3) papillary-mesenchymal bodies (PMB); 4) amyloid; 5) mitotic figures; 6) apoptotic cells; 7) inflammation; 8) granuloma; and 9) calcification. A judgment was made regarding diagnosis. The patients' medical records were subsequently reviewed for clinical f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
1
6

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(35 citation statements)
references
References 17 publications
1
27
1
6
Order By: Relevance
“…Although both lesions were clinically diagnosed as nodular BCC, each clinically showed a well-circumscribed, symmetrical lesion without ulceration, but neither the Although trichoblastoma is clearly a benign neoplasm of follicular germinative cells, and BCC is its malignant counterpart, the two are considered to represent different points along the same neoplastic spectrum based on the common molecular pathogenesis. [1][2][3] There are four types of lesions demonstrating the same neoplastic spectrum: (1) a lesion with almost equal histopathological components of both trichoblastoma and BCC and a clear border between the two components, 8,9,14 (2) trichoblastoma with a foci of BCC, 13 (3) BCC with a foci of trichoblastoma, 10,11,15,16 and (4) diagnostically confusing cases, whether trichoblastoma or BCC, with both features having no clear border between the two components. 12 There have been various attempts to differentiate trichoblastoma from BCC using immunohistochemical markers, including CD34-positive stromal cells or the staining pattern of bcl-2 in neoplastic aggregations.…”
Section: Discussionmentioning
confidence: 98%
“…Although both lesions were clinically diagnosed as nodular BCC, each clinically showed a well-circumscribed, symmetrical lesion without ulceration, but neither the Although trichoblastoma is clearly a benign neoplasm of follicular germinative cells, and BCC is its malignant counterpart, the two are considered to represent different points along the same neoplastic spectrum based on the common molecular pathogenesis. [1][2][3] There are four types of lesions demonstrating the same neoplastic spectrum: (1) a lesion with almost equal histopathological components of both trichoblastoma and BCC and a clear border between the two components, 8,9,14 (2) trichoblastoma with a foci of BCC, 13 (3) BCC with a foci of trichoblastoma, 10,11,15,16 and (4) diagnostically confusing cases, whether trichoblastoma or BCC, with both features having no clear border between the two components. 12 There have been various attempts to differentiate trichoblastoma from BCC using immunohistochemical markers, including CD34-positive stromal cells or the staining pattern of bcl-2 in neoplastic aggregations.…”
Section: Discussionmentioning
confidence: 98%
“…5 Histopatolojik olarak konvansiyonel ve desmoplastik olmak üzere iki tipi mevcuttur. 6 Tanıda tıraş biyopsi ve insizyonel biyopsi kullanılır.…”
Section: Discussionunclassified
“…[3] The papillary mesenchymal bodies are distinct fibroblastic aggregations that represent abortive attempts to form papillary mesenchyme responsible for hair induction. [3] Trichelemmal keratinization, which is abrupt and complete is represented by islands of basaloid cells surrounded by glassy eosinophilic areas.…”
Section: Discussionmentioning
confidence: 99%